Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
Diabetes mellitus (DM) is believed to be the third most frequent direct cause of death after cardiovascular and oncological diseases. Therefore, solutionof DM-related problems is a major challenge facing health authorities in many countries. No doubt, strict control of glycemia is an indispensableco...
Enregistré dans:
| Auteurs principaux: | Alexander Sergeevich Ametov, Ekaterina Vladimirovna Karpova |
|---|---|
| Format: | article |
| Langue: | EN RU |
| Publié: |
Endocrinology Research Centre
2010
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/79d30283e9ec4221af5b1c7afe77a1d9 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
par: Editorial team Diabetes Mellitus
Publié: (2009) -
Rannyaya kombinirovannaya terapiya pri sakharnom diabete 2 tipa
par: Alexander Sergeevich Ametov, et autres
Publié: (2011) -
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
par: Editorial team Diabetes Mellitus
Publié: (2012) -
Vildagliptin and its role in the treatment of diabetes mellitus
par: Yury Shavkatovich Khalimov
Publié: (2010) -
The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
par: Alexander Sergeevich Ametov, et autres
Publié: (2011)